The Wall Street Journal-20080129-Noted ---

Return to: The_Wall_Street_Journal-20080129

Noted ...

Full Text (289  words)

CORNERSTONE PROMOTION Inc. (New York) -- This marketing firm appointed Jeff Tammes senior vice president of strategic marketing, effective immediately. The post is new. Mr. Tammes, 32 years old, continues his responsibilities as vice president of marketing.

---

IKON OFFICE SOLUTIONS Inc. (Malvern, Pa.) -- Jeffrey Hickling was appointed president, IKON U.S., a part of this document management company, effective immediately. The post is new. Mr. Hickling, 52, will continue his responsibilities as senior vice president, operations.

---

PERKINELMER Inc. (Waltham, Mass.) -- This health-sciences company named Robert F. Friel chief executive, effective Feb. 1. Mr. Friel, 52, succeeds Gregory L. Summe, 51, who continues as executive chairman. Mr. Friel was president and chief operating officer. He continues as president. The post of operating chief is eliminated.

---

QUADRANGLE GROUP LLC. (New York) -- This private investment firm appointed Doug Kramer managing principal and chief operating officer. The post of operating chief is new. Mr. Kramer, 37, was head of global manager strategies group at Goldman Sachs Group Inc.

---

SONY/ATV MUSIC PUBLISHING LLC. (New York) -- This music publishing company named Jody Gerson co-president, Sony/ATV Music Publishing USA, effective immediately. The post is new. Ms. Gerson, 46, is responsible for operations in Los Angeles. Ms. Gerson was executive vice president creative, EMI Music Publishing US. She shares the co-president title with Danny Strick. Mr. Strick, 48, continues responsibilities for operations on the East Coast.

---

TRANSGENOMIC Inc. (Omaha, Neb.) -- This global biotechnology company named Eric Kaldjian chief scientific officer, effective immediately. Mr. Kaldjian, 46, succeeds Craig Tuttle, who was serving in the interim. Mr. Tuttle, 55, continues as president and chief executive. Mr. Kaldjian was executive director, medical sciences at Gene Logic, Inc., now Ore Pharmaceuticals Inc.